Search Results - "Madjlessi, Nika"

The “spaghetti technique”: An alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma) by Gaudy-Marqueste, Caroline, MD, PhD, Perchenet, Anne-Sophie, MD, Taséi, Anne-Marie, MD, Madjlessi, Nika, MD, Magalon, Guy, MD, PhD, Richard, Marie-Aleth, MD, PhD, Grob, Jean-Jacques, MD, PhD

“…Background Lentigo maligna (LM) and acral lentiginous melanoma (ALM) are often large and clinically ill defined. The surgical challenge is to spare tissue…”
Get full text

Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review by Gauci, Marie-Léa, Laly, Pauline, Vidal-Trecan, Tiphaine, Baroudjian, Barouyr, Gottlieb, Jérémy, Madjlessi-Ezra, Nika, Da Meda, Laetitia, Madelaine-Chambrin, Isabelle, Bagot, Martine, Basset-Seguin, Nicole, Pages, Cécile, Mourah, Samia, Boudou, Philippe, Lebbé, Céleste, Gautier, Jean-François

“…Anti-PD-1 antibody treatment is approved in advanced melanoma and provides median overall survival over 24 months. The main treatment-related side effects are…”
Get full text

BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanoma by Roux, Jennifer, Pages, Cecile, Malouf, Diane, Basset Seguin, Nicole, Madjlessi, Nika, Baccard, Michel, Comte, Christelle, Archimbaud, Alain, Battistella, Maxime, Viguier, Manuelle, Mourah, Samia, Bagot, Martine, Lebbe, Céleste

“…In around 50% of melanomas, the BRAF V600 mutation, resulting in an activation of the MAP kinase pathway, is detected. BRAF inhibitors have shown remarkable…”
Get full text

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients by Amode, Reyhan, Baroudjian, Barouyr, Kowal, Anita, Jebali, Majdi, Allayous, Clara, Bagot, Martine, Madjlessi, Nika, Roux, Jennifer, Viguier, Manuelle, Basset Seguin, Nicole, Porcher, Raphaël, Pagès, Cécile, Lebbé, Céleste

“…In patients with ipilimumab (IPI)-refractory melanoma, the anti-programmed cell death proteins 1 (PD1s) nivolumab (NIV) and pembrolizumab (PEM) are considered…”
Get full text

Squamous Cell Carcinoma Following Photodynamic Therapy for Cutaneous Bowen's Disease in a Series of 105 Patients by Ratour-Bigot, Carole, Chemidling, Mireille, Montlahuc, Claire, Abirached, Georges, Madjlessi, Nika, Bullier, Chantal, Battistella, Maxime, Bagot, Martine, Lebbe, Céleste, Basset-Seguin, Nicole

“…Photodynamic therapy (PDT) is an alternative to surgery for Bowen's disease. This monocentric retrospective study included 105 patients with Bowen's disease,…”
Get full text

Melapred: first susceptibility test to sporadic melanoma in daily dermatological practice by Soufir, Nadem, Benfodda, Meriem, Gazal, Steven, Descamps, Vincent, Madjlessi, Nika, Lebbe, Celeste, Basset-Seguin, Nicole, Archimbaud, Alain, Opletalova, Kristina, Vuong, Valerie, Nicaise Bergere, Caroline, Massart-Manil, Sandrine, Machuel, Bruno, Saiag, Philippe, Merrouche, Yacine, Bensussan, Armand, Nagore, Eduardo, Kumar, Rajiv, Grange, Florent

“…Abstract only…”
Get full text

Single-center experience in French Temporary Authorization for Use (TAU) metastatic melanoma program with ipilimumab by Chasset, Francois, Pagès, Cécile, Biard, Lucie, Roux, Jennifer, Sidina, Irina, Madelaine, Isabelle, Basset-Seguin, Nicole, Viguier, Manuelle, Madjlessi, Nika, Schneider, Pierre, Bagot, Martine, Resche-Rigon, Matthieu, Lebbe, Celeste

“…Abstract only…”
Get full text

Ultrasound-guided core needle biopsy of superficial lymph nodes: an alternative to fine-needle aspiration cytology for the diagnosis of lymph node metastasis in cutaneous melanoma by Bohelay, Gérôme, Battistella, Maxime, Pagès, Cécile, de Margerie-Mellon, Constance, Basset-Seguin, Nicole, Viguier, Manuelle, Kerob, Delphine, Madjlessi, Nika, Baccard, Michel, Archimbaud, Alain, Comte, Christelle, Mourah, Samia, Porcher, Raphael, Bagot, Martine, Janin, Anne, De Kerviler, Eric, Lebbé, Céleste

“…To investigate the diagnostic value of ultrasound-guided core needle biopsy (US-CNB) in suspected cases of lymph node metastasis from cutaneous melanoma. All…”
Get full text

Ultrasound-guided core needle biopsy (US-CNB) of superficial lymph nodes: An alternative to fine-needle aspiration cytology (FNAC) for the diagnosis of lymph node metastasis in melanoma by Bohelay, Gerome, Battistella, Maxime, Pagès, Cécile, Basset-Seguin, Nicole, Viguier, Manuelle, Kerob, Delphine, Madjlessi, Nika, Baccard, Michel, Comte, Christelle, Archimbaud, Alain, de Margerie, Constance, Mourah, Samia, Porcher, Raphael, Bagot, Martine, Janin, Anne, de Kerviler, Eric, Lebbe, Celeste

“…Abstract only…”
Get full text

Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids by Chasset, François, Pages, Cécile, Biard, Lucie, Roux, Jennifer, Sidina, Irina, Madelaine, Isabelle, Basset-Seguin, Nicole, Viguier, Manuelle, Madjlessi-Ezra, Nika, Schneider, Pierre, Bagot, Martine, Resche-Rigon, Matthieu, Lebbe, Céleste

“…Ipilimumab is an anti-CTLA-4 antibody which has recently been approved in Europe as a monotherapy in the treatment of metastatic melanoma.We report a…”
Get full text

Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trial by Fennira, Feriel, Pagès, Cecile, Schneider, Pierre, Sidina, Irina, Viguier, Manuelle, Basset-Seguin, Nicole, Madjlessi-Ezra, Nika, Madelaine, Isabelle, Bagot, Martine, Battistella, Maxime, Porcher, Raphael, Mourah, Samia, Lebbé, Celeste

“…Vemurafenib, a selective BRAF inhibitor, has recently shown an improved overall survival (OS) in metastatic melanoma with V600E mutation in phase 2 and 3…”
Get full text

Risk factors in elderly people for lentigo maligna compared with other melanomas: a double case-control study by Gaudy-Marqueste, Caroline, Madjlessi, Nika, Guillot, Bernard, Avril, Marie-Françoise, Grob, Jean-Jacques

“…To assess lentigo maligna (LM) as an epidemiological entity separate from other melanomas (OMs) in elderly people. Double age- and sex-matched case-control…”
Get more information